Lansoÿl

Liquid Paraffin, the active ingredient in Lansoÿl, is a mineral oil presented as an oral liquid for oral use. It treats constipation, occasional constipation and is used for bowel cleansing in adults and children when appropriate. GNH USA supplies Lansoÿl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoÿl is a mineral oil laxative that acts on the gastrointestinal tract to ease stool passage. - Constipation: softens stool and facilitates its movement through the colon. - Occasional constipation: provides temporary relief without stimulating intestinal muscles. - Bowel cleansing: prepares the bowel for diagnostic procedures by lubricating intestinal contents.

Lansoÿl may cause unwanted reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal cramping or discomfort. - Oily or greasy stools. - Nausea or mild stomach upset. - Flatulence or bloating. - Diarrhea if excessive dose is taken.

Serious or Rare Side Effects: - Aspiration pneumonia if the liquid is inhaled. - Allergic reactions such as rash, itching, or swelling. - Rectal irritation or bleeding. - Severe abdominal pain indicating obstruction. - Persistent vomiting or inability to retain the product.

Before using Lansoÿl, consider the following safety measures. - Children: Use only under medical supervision and follow pediatric dosing guidelines. - Bowel obstruction: Avoid in patients with known intestinal blockage or severe constipation. - Prolonged use: Do not use continuously without physician advice, as it may affect nutrient absorption. - Vitamin absorption: Monitor for possible reduction of fat‑soluble vitamin levels during extended therapy. - Storage: Store at ambient temperature: keep in the original container, protect from moisture and direct heat.

Lansoÿl can affect the absorption and efficacy of other medicines.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce the laxative effect. - Other lubricating laxatives: risk of excessive softening of stool. - Warfarin: potential alteration of vitamin K absorption affecting anticoagulation.

Moderate Interactions (Monitor Closely): - Fat‑soluble vitamins (A, D, E, K): may have decreased absorption. - Oral medications taken simultaneously: may experience delayed absorption; separate dosing by at least 2 hours. - Lipid‑based formulations: possible interference with drug dissolution.